Power Law company profile

Aetion

Biotech & Life Sciences · New York City, United States · Founded 2012 Colt

Delivering real-world evidence (RWE) and outcomes-based analytics solutions to life science companies and payers

Valuation

$500M–1B

Latest valuation · 2026

Unlock exact value

Revenue

$10–50M

Latest reported FY

Unlock exact value

Headcount

100–500

Current team size

Unlock exact value

Featured in $1B+ revenueColt · Power Law growth-stage

Investors

16 investors on Aetion's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 2 investors entered at this stage

Flare Capital Partners

Lakestar

Series B+ 14 investors entered at this stage

Johnson & Johnson Innovation

NEC Corporation

Oxeon

UCB Ventures

EDBI

Greenspring Associates

Amgen Ventures

McKesson Ventures

Horizon Blue Cross Blue Shield of New Jersey

Sanofi

Global footprint

Where Aetion has talent and traffic

AI talent share

8.5% of workforce is AI talent
(15 of 177 staff)

Core AI31.69%

Other AI126.78%

Non-AI workforce16291.53%

Workforce by country

🇺🇸 United States · New York City HQ

Book a demo for the full country breakdown

Web traffic by country

10K monthly visits
across markets

🇺🇸 United States51%

🇮🇳 India32%

🇮🇩 Indonesia9%

🇪🇸 Spain5%

🇪🇬 Egypt4%

Top 5 markets shown

Market sentiment

What the market is saying about Aetion

An AI-synthesized read of the highest-engagement posts about Aetion on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Aetion on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles